Back to Journals » ClinicoEconomics and Outcomes Research » Volume 14
Original Research
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
![Plain language summary](assets/img/article_icons/plain-language.png)
Sodium-Glucose Cotransporter 2 Inhibitor Use Among Individuals Age <65 with Type 2 Diabetes and Heart Failure with Reduced Ejection Fraction: A Cost–Benefit Analysis
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
7,715 | Dovepress* | 7,587+ | 251 | 7,838 | |
PubMed Central* | 128 | 82 | 210 | ||
Totals | 7,715 | 333 | 8,048 | ||
*Since 9 July 2022 |
Total mentioned | Delicious | Others | |||
---|---|---|---|---|---|
4 | 0 | 0 | 0 | 2 | 2 |
View citations on PubMed Central and Google Scholar